Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lowes | LOW | Mar 31, 2025 | 233.23 | +2.11 |
LPL Financial | LPLA | Mar 31, 2025 | 327.14 | -2.89 |
LQR House | YHC | Mar 31, 2025 | 0.20 | -7.75 |
LQR House | LQR | Mar 31, 2025 | 1.15 | 0.00 |
LSB Industries | LXU | Mar 31, 2025 | 6.59 | 0.00 |
LSI Industries | LYTS | Mar 31, 2025 | 17.00 | -1.11 |
Ltc Properties | LTC | Mar 31, 2025 | 35.45 | +0.57 |
Lucas GC | LGCL | Mar 31, 2025 | 0.49 | +4.04 |
Lucid Diagnostics | LUCD | Mar 31, 2025 | 1.49 | -5.70 |
Lucid Group | LCID | Mar 31, 2025 | 2.42 | +4.31 |
Lucky Strike Entertainment A | LUCK | Mar 31, 2025 | 9.76 | -1.51 |
Luda Technology Group Limited | LUD | Mar 31, 2025 | 3.61 | 0.00 |
Lufax ADR | LU | Mar 31, 2025 | 2.97 | +0.34 |
Lululemon Athletica | LULU | Mar 31, 2025 | 283.06 | -3.41 |
Lulus Fashion Lounge | LVLU | Mar 31, 2025 | 0.40 | +2.83 |
Lumen Technologies | LUMN | Mar 31, 2025 | 3.92 | -0.51 |
Lument Finance Trust | LFT | Mar 31, 2025 | 2.61 | -2.61 |
Lument Finance Trust A Pref | LFT-A | Mar 31, 2025 | 22.84 | 0.00 |
Lumentum | LITE | Mar 31, 2025 | 62.34 | -0.38 |
Luminar Technologies A | LAZR | Mar 31, 2025 | 5.39 | -10.39 |
Luokung Technology | LKCO | Mar 31, 2025 | 0.81 | 0.00 |
Luxfer | LXFR | Mar 31, 2025 | 11.86 | +2.60 |
Lxp Industrial Trust | LXP | Mar 31, 2025 | 8.65 | -1.14 |
LXP Industrial Trust C Pref | LXP-C | Mar 31, 2025 | 45.60 | -1.85 |
Lyell Immunopharma | LYEL | Mar 31, 2025 | 0.54 | -0.59 |
Lyft A | LYFT | Mar 31, 2025 | 11.87 | +2.59 |
LyondellBasell Industries Nv A | LYB | Mar 31, 2025 | 70.40 | +0.83 |
Lyra Therapeutics | LYRA | Mar 31, 2025 | 0.13 | -9.07 |
Lytus Technologies | LYT | Mar 31, 2025 | 0.10 | 0.00 |
LZ Technology B | LZMH | Mar 31, 2025 | 6.91 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.